![In silico Immunogenicity Assessment for Sequences Containing Unnatural Amino Acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements](https://epivax.com/wp-content/uploads/2023/03/UAA-poster-642x675.png)
![In silico Immunogenicity Assessment for Sequences Containing Unnatural Amino Acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements](https://epivax.com/wp-content/uploads/2023/03/UAA-poster-642x675.png)
![Promiscuous T Cell Binding Epitopes in Two Osteoporosis Medications Lead to Different Immunogenicity Profiles: A Tale of Two Peptides](https://epivax.com/wp-content/uploads/2023/03/Promiscuous-T-Cell-Binding-Epitopes-in-Two-Osteoporosis-Medications-Lead-to-Different-Immunogenicity-Profiles-A-Tale-of-Two-Peptides-652x675.png)
Promiscuous T Cell Binding Epitopes in Two Osteoporosis Medications Lead to Different Immunogenicity Profiles: A Tale of Two Peptides
Promiscuous T Cell Binding Epitopes in Two Osteoporosis Medications Lead to Different Immunogenicity Profiles: A Tale of Two Peptides![In silico immunogenicity assessment for sequences containing unnatural amino acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements](https://epivax.com/wp-content/uploads/2022/10/Mattei_2022_BPS_UAA_splash-1043x675.png)
In silico immunogenicity assessment for sequences containing unnatural amino acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements
![Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide](https://epivax.com/wp-content/uploads/2019/09/EpiVax_PANDA_Taspoglutide_April_19_Final-1-pdf.jpg)
Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide
EpiVax_PANDA_Taspoglutide_April_19_Final![Predicting Immunogenicity of Peptide Drugs and Their Impurities Using in Silico Tools: Taspoglutide Case Study](https://epivax.com/wp-content/uploads/2019/05/EpiVax_TaspoglutidePoster_14May19-pdf.jpg)